Prevalence of human herpesvirus 8 DNA sequences in human immunodeficiency virus-negative individuals without Kaposi's sarcoma in Greece

In Vivo

Volumn 19, Issue 4, 2005, Pages 729-732

  Zavos, George ^a   Gazouli, Maria ^b   Papaconstantinou, Ioannis ^a   Lukas, John C ^c   Zografidis, Anastasios ^a   Kostakis, Alkiviadis ^a   Nasioulas, Georgios ^d  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d HYGEIA HOSPITAL   (Greece)

Author keywords

Greece; HHV8; Kaposi's sarcoma

Indexed keywords

DNA; VIRUS DNA;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; EXPOSURE; FEMALE; GENETIC ANALYSIS; GEOGRAPHIC ORIGIN; GREECE; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RATE; KAPOSI SARCOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PREVALENCE; SEX DIFFERENCE; SEXUAL TRANSMISSION; SOUTHERN EUROPE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 21344470450     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Huang VQ, Li JJ, Kaplan MH, Poisez B, Katabira E, Zhang WC, Feiner D and Friedman-Kien AE: Human herpes virus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345: 759-761, 1995.
2. Boshoff C, Whitby D, Hatzioannou T, Boshoff C, Fisher C, van der Walt J, Hatzakis A, Weiss R and Schulz T: Kaposi's sarcoma associated herpes virus in HIV-negative Kaposi's sarcoma. Lancet 345: 1043-1044, 1995.
3. Cattani P, Cerimele F, Porta D, Graffeo R, Ranno S, Marchetti S, Ricci R, Capodicasa N, Fuga L, Amico R, Cherchi G, Gazzilli M, Zanetti S and Fadda G: Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect 9: 274-279, 2003.
4. Huang LM, Huang SY, Chen MY, Chao MF, Lu CY, Tien HF, Lee CY and Jeang KT: Geographical differences in human herpesvirus 8 seroepidemiology: a survey of 1201 individuals in Asia. J Med Virol 60: 290-293, 2000.
5. Serraino D, Toma L, Andreoni M, Butto S, Tchangmena O, Sarmati L, Monini P, Franceschi S, Ensoli B and Rezza G: A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and central Africa and in the Mediterranean area. Eur J Epidemiol 17: 871-876, 2001.
6. Cattani P, Capuano M, Cerimele F, La Parola IL, Santangelo R, Masini C, Cerimele D and Fadda G: Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 37: 1150-1153, 1999.
7. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y and Moore PS: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2: 925-928, 1996.
8. Lennette ET, Blackbourn DJ and Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348: 858-861, 1996.
9. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D and Kedes DH: Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338: 948-954, 1998.
10. Belec L, Cancre N, Hallouin MC, Morvan J, Si Mohamed A and Gresenguet G: High prevalence in central Africa of blood donors who are potentially infectious for human herpesvirus 8. Tranfusion 38: 771-775, 1998.
11. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, Silvel B, Hart CA and Schulz TF: Prevalence and transmission of Kaposi's sarcoma- associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77: 817-820, 1998.
12. Schulz TF: Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J Antimicrob Chemother 45: 15-27, 2000.
13. Gomez-Roman J, Ocejo-Vinyals G, Sanchez-Velasco P, Leyva-Cobian F and Val-Bernal JF: Presence of human herpesvirus 8 DNA sequences in renal transplantation-associated pleural Kaposi sarcoma. Arch Pathol Lab Med 123: 1269-1273, 1999.
14. Zong JC, Ciufo DM, Alcendor DJ, Wan X, Nicholas J, Browning PJ, Rady PL, Tyring SK, Orenstein JM, Rabkin CS, Su IJ, Powell KF, Croxson M, Foreman KE, Alkan BJ and Hayward GS: High-level variability in the ORF-K1 membrane protein gene at left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73: 4156-4170, 1999.
15. Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, Orenstein JM, Reitz MS and Hayward GS: Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the righthand end. J Virol 73: 6646-6660, 1999.
16. Felsenstein J: PHYLIP Version 3.5c, University of Washington, Seattle, USA, 1993.
17. Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Butto S, Lodi G, Di Carlo A, Levy JA and Ensoli B: Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 77: 361-365, 1998.
18. Angeloni A, Heston L, Uccini S, Sirianni MC, Cottoni F, Masala MV, Cerimele D, Lin SF, Sun R, Rigsby M, Faggioni A and Miller G: High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 177: 1715-1718, 1998.
19. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA and Moore PS: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 349: 1133-1138, 1996.
20. Franceschi S and Geddes M: Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori 81: 308-314, 1995.
21. Rappersberger K, Tschachler E, Zonzits E, Gillitzer R, Hatzakis A, Kaloterakis A, Mann DL, Popow-Kraupp T, Biggar RJ and Berger R: Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 95: 371-381, 1990.
22. Kasolo FS, Monze M, Obel N, Anderson RN, French C and Gompels UA: Sequence analyses of human herpesvirus-8 strains from both African human immunodeficiency virus-negative and -positive childhood endemic Kaposi's sarcoma show a close relationship with strains identified in febrile children and high variation in the K1 glycoprotein. J Gen Virol 79: 3055-3065, 1998.
23. Cook PM, Whitby D, Calabro ML, Luppi M, Kakoola M, Hjalgrim DN, Ariyoshi H, Ensoli B, Davison AJ and Schulz TF: Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. AIDS 13: 1165-1176, 1999.
24. Stratigos JD, Katoulis AC and Stavrianeas NG: An overview of classic Kaposi's sarcoma in Greece. Adv Exp Med Biol 455: 503-506, 1999.